Download PDF
Semin Liver Dis 2003; 23(2): 137-148
DOI: 10.1055/s-2003-39943
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

GB Virus Type C/Hepatitis G Virus

Jack T. Stapleton
  • Professor, Medical Service, Iowa City VA Hospital and Department of Internal Medicine, University of Iowa. Iowa City, Iowa
Further Information

Publication History

Publication Date:
11 June 2003 (online)

    Permissions and Reprints

ABSTRACT

After hepatitis G virus (HGV) and GB virus type C (GBV-C) were independently discovered, it was determined that they were two isolates of the same virus. The HGV/GBV-C genome sequence and organization are closely related to hepatitis C virus. Although HGV/GBV-C infection is common and frequently persists in humans, infection has not been found to be associated with any known disease state. Because this virus is not associated with acute or chronic hepatitis, most people refer to it as GBV-C. GBV-C appears to grow in lymphocytes and not in hepatocytes, and presumably this is why the virus does not cause liver disease. Recent studies suggest that GBV-C infection in HIV-positive people is associated with prolonged survival. In vitro coinfection of human lymphocytes with GBV-C and HIV lead to decreased HIV replication. Further understanding of the mechanism(s) responsible for this interaction with HIV may provide novel approaches for treating HIV and AIDS.

KEYWORDS

GB virus - flavivirus - HCV

REFERENCES

  • 1 Deinhardt F, Holmes A W, Capps R B, Popper H. Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions.  J Exp Med . 1967;  125 673-688
    CrossrefPubMedGoogle Scholar
  • 2 Parks W P, Melnick J L. Attempted isolation of hepatitis viruses in marmosets.  J Infect Dis . 1969;  120 539-547
    PubMedGoogle Scholar
  • 3 Tabor E, Seeff L B, Gerety R J. Lack of susceptibility of marmosets to human non-A, non-B hepatitis.  J Infect Dis . 1979;  140 794-797
    PubMedGoogle Scholar
  • 4 Tabor E, Peterson D A, April M, Seeff L B, Gerety R J. Transmission of human non-A, non-B hepatitis to chimpanzees following failure to transmit GB agent hepatitis.  J Med Virol . 1980;  5 103-108
    PubMedGoogle Scholar
  • 5 Simons J N, Pilot-Matias T J, Leary T P. et al . Identification of two flavivirus-like genomes in the GB hepatitis agent.  Proc Natl Acad Sci USA . 1995;  92 3401-3405
    PubMedGoogle Scholar
  • 6 Muerhoff A S, Leary T P, Simons J N. et al . Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis.  J Virol . 1995;  69 5621-5630
    PubMedGoogle Scholar
  • 7 Linnen J, Wages J, Zhang-Keck Z-Y. et al . Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent.  Science . 1996;  271 505-508
    PubMedGoogle Scholar
  • 8 Simons J N, Leary T P, Dawson G J. et al . Isolation of novel virus-like sequences associated with human hepatitis.  Nat Med . 1995;  1 564-569
    PubMedGoogle Scholar
  • 9 Leary T P, Muerhoff A S, Simons J N. et al . Sequence and genomic organization of GBV-C: A novel member of the Flaviviridae associated with human non-A-E hepatitis.  J Med Virol . 1996;  48 60-67
    CrossrefPubMedGoogle Scholar
  • 10 Dickens T, Lemon SM.. GB virus C, hepatitis G virus, or human orphan flavivirus?.  Hepatology . 1997;  25 1285-1286
    CrossrefPubMedGoogle Scholar
  • 11 Dawson G J, Schlauder G G, Pilot-Matias T J. et al . Prevalence studies of GB virus-C using reverse-transcriptase-polymerase chain reaction.  J Med Virol . 1996;  50 97-103
    CrossrefPubMedGoogle Scholar
  • 12 Xiang J, Wunschmann S, Schmidt W N, Shao J, Stapleton J T. Full-length GB virus C (hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells.  J Virol . 2000;  74 9125-9133
    CrossrefPubMedGoogle Scholar
  • 13 Lefrère J J, Roudot-Thoraval F, Roudot-Thoraval R. et al . GBV-C/hepatitis G virus (HGV) RNA load in immunodeficient individuals and in immunocompetent individuals.  J Med Virol . 1999;  59 32-37
    CrossrefPubMedGoogle Scholar
  • 14 Tillmann H L, Heiken H, Knapik-Botor A. et al . Infection with GB virus C and reduced mortality among HIV-infected patients.  N Engl J Med . 2001;  345 715-724
    CrossrefPubMedGoogle Scholar
  • 15 Lau D T, Miller K D, Detmer J. et al . Hepatitis G virus and human immunodeficiency virus co-infection: response to interferon-alpha therapy.  J Infect Dis . 1999;  180 1334-1337
    CrossrefPubMedGoogle Scholar
  • 16 Toyoda H, Takahashi I, Fukuda Y, Hayakawa K, Takamatsu J. Comparison of characteristics between patients with GB virus C/hepatitis G virus (GBV-C/HGV) RNA and those with GBV-C/HGV E2-antibody in patients with hemophilia.  J Med Virol . 2000;  60 34-38
    CrossrefPubMedGoogle Scholar
  • 17 Masuko K, Mitsui T, Iwano K. et al . High prevalence of GB virus C in patients on maintenance hemodialysis.  N Engl J Med . 1996;  334 1485-1490
    CrossrefPubMedGoogle Scholar
  • 18 Alter H J. G-pers creepers, where'd you get those papers?.  <~>A reassessment of the literature on the hepatitis G virus. Transfusion . 1997;  37 569-572
    PubMedGoogle Scholar
  • 19 Alter M J, Gallagher M, Morris T T. et al . Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection.  N Engl J Med . 1997;  336 741-746
    CrossrefPubMedGoogle Scholar
  • 20 Alter H J, Nakatsuji Y, Melpolder J. et al . The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.  N Engl J Med . 1997;  336 747-754
    CrossrefPubMedGoogle Scholar
  • 21 Gutierrez R A, Dawson G J, Knigge M F. et al . Seroprevalence of GB virus C and persistence of RNA and antibody.  J Med Virol . 1997;  53 167-173
    CrossrefPubMedGoogle Scholar
  • 22 Schaluder G G, Dawson G J, Simons J N. et al . Molecular and serologic analysis in the transmission of the GB hepatitis agents.  J Med Virol . 1995;  46 81-90
    PubMedGoogle Scholar
  • 23 Pilot-Matias T J, Carrick R J, Coleman P F. et al . Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker.  Virology . 1996;  225 282-292
    CrossrefPubMedGoogle Scholar
  • 24 Thomas D L, Vlahov D, Alter H J. et al . Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection.  J Infect Dis . 1998;  177 539-542
    PubMedGoogle Scholar
  • 25 Feucht H H, Zollner B, Polywka S. et al . Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients.  Hepatology . 1997;  26 491-494
    CrossrefPubMedGoogle Scholar
  • 26 Heringlake S, Ockenga J, Tillmann H L. et al . GB virus C/ hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients?.  J Infect Dis . 1998;  177 1723-1726
    PubMedGoogle Scholar
  • 27 Tacke M, Schmolke S, Schlueter V. et al . Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors.  Hepatology . 1997;  26 1626-1633
    PubMedGoogle Scholar
  • 28 Klinzman D, Katz L, George S L. et al .GBV-C prevalence in different populations suggests increased clearance with parenteral transmission. Oral presentation at the meeting on Viral Hepatitis and Liver Disease. April 8, 2003; Sydney, Australia
    Google Scholar
  • 29 Devereux H, Sabin C A, Kinson Z. et al . Influence of HIV-1 infection on GBV-C infection in multiply infected haemophilic patients.  J Med Virol . 1998;  56 316-320
    CrossrefPubMedGoogle Scholar
  • 30 Williams C M, Klinzman D, Yamashita T. et al .Persistent GBV-C virus type C (GBV-C) infection is associated with decreased risk of death in HIV-seroconvertors in the Multicenter AIDS Cohort Study (MACS). Oral presentation at the Conference on Retroviruses and Opportunistic Infections. February 13, 2003; Boston, MA
    Google Scholar
  • 31 Jarvis L M, Davidson F, Hanely J P. et al . Infection with hepatitis G virus among recipients of plasma products.  Lancet . 1996;  348 1352-1355
    CrossrefPubMedGoogle Scholar
  • 32 Stapleton J T. Hepatic and pancreatic dysfunction in HIV-infected individuals (in press). In: Swindells S, ed. 2002
    Google Scholar
  • 33 Simons J N, Desai S M, Mushahwar I K. The GB viruses.  Curr Top Microbiol Immunol . 2000;  242 341-375
    PubMedGoogle Scholar
  • 34 Sarrazin C, Ruster B, Lee J-H. et al . Prospective follow-up of patients with GBV-C/HGV infection: specific mutational patterns, clinical outcome, and genetic diversity.  J Med Virol . 2000;  62 191-198
    CrossrefPubMedGoogle Scholar
  • 35 Scallan M F, Clutterbuck D, Jarvis L M, Scott G R, Simmonds P. Sexual transmission of GB virus C/hepatitis G virus.  J Med Virol . 1998;  55 203-208
    CrossrefPubMedGoogle Scholar
  • 36 Nerurkar V R, Chua P K, Hoffman P R. et al . High prevalence of GB virus C/hepatitis G virus infection among homosexual men infected with human immunodeficiency virus type 1: evidence for sexual transmission.  J Med Virol . 1998;  56 123-127
    CrossrefPubMedGoogle Scholar
  • 37 Bourlet T, Guglielminotti C, Evrard M. et al . Prevalence of GBV-C/hepatitis G virus RNA and E2 antibody among subjects infected with human immunodeficiency virus type 1 after parenteral or sexual exposure.  J Med Virol . 1999;  58 373-377
    CrossrefPubMedGoogle Scholar
  • 38 Hollingsworth R C, Minton E J, Fraser-Moodie C. et al . Hepatitis G infection: role in cryptogenic chronic liver disease and primary liver cell cancer in the UK. Trent Hepatitis C Virus Study Group.  J Viral Hepat . 1998;  4 165-169
    PubMedGoogle Scholar
  • 39 Xiang J, Wunschmann S, Diekema D J. et al . Effect of co-infection with GB virus C (hepatitis G virus) on survival among patients with HIV infection.  N Engl J Med . 2001;  345 707-714
    CrossrefPubMedGoogle Scholar
  • 40 Kozal M J, Friedland G, Kyriakides T. et al .Prevalence of HIV and GBV-C co-infection and the likelihood of HIV genotypic resistance development. Abstract presented at the Retrovirus Conference. February 25, 2002; Seattle, WA
    Google Scholar
  • 41 Stapleton J T, Xiang J, George S, Klinzman D. Evidence for delayed human immunodeficiency virus (HIV) disease progression in HIV-GB virus C co-infected individuals. In: Margolis H, Alter MJ, Liang TJ, Dienstag JL, eds. Viral Hepatitis and Liver Disease London: International Medical Press 2002: 469-472
    Google Scholar
  • 42 Lefrère J J, Sender A, Mercier B. et al . High rate of GB virus type C/HGV transmission from mother to infant: possible implications for the prevalence of infection in blood donors.  Transfusion . 2000;  40 602-607
    CrossrefPubMedGoogle Scholar
  • 43 Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology.  Lancet . 1995;  346 1131-1132
    CrossrefPubMedGoogle Scholar
  • 44 Heringlake S, Osterkamp S, Trautwein C. et al . Association between fulminant hepatic failure and a strain of GBV virus C.  Lancet . 1996;  348 1626-1629
    CrossrefPubMedGoogle Scholar
  • 45 Tanaka E, Alter H J, Nakatsuji Y. et al . Effect of hepatitis G virus infection on chronic hepatitis C.  Ann Intern Med . 1996;  125 740-743
    PubMedGoogle Scholar
  • 46 Kuroki T, Nishiguchi S, Tanaka M, Enomoto M, Kobayashi K. Does GBV-C cause fulminant hepatitis in Japan?.  Lancet . 1996;  347 908
    PubMedGoogle Scholar
  • 47 Sallie R, Shaw J, Mutimer D. GBV-C virus and fulminant hepatic failure.  Lancet . 1996;  347 1552
    PubMedGoogle Scholar
  • 48 Kanda T, Yokosuka O, Ehata T. et al . Detection of GBV-C RNA in patients with non-A-E fulminant hepatitis by reverse-transcription polymerase chain reaction.  Hepatology . 1997;  25 1261-1265
    CrossrefPubMedGoogle Scholar
  • 49 Rambusch E G, Wedemeyer H, Tillmann H L, Heringlake S, Manns M P. Significance of co-infection with hepatitis G virus for chronic hepatitis C-a review of the literature.  Z Gastroenterol . 1998;  36 41-53
    PubMedGoogle Scholar
  • 50 Fried M W, Khudyakov Y E, Smallwood G A. et al . Hepatitis G virus co-infection in liver transplant recipients with chronic hepatitis C and non-viral chronic liver disease.  Hepatology . 1997;  25 1271-1275
    CrossrefPubMedGoogle Scholar
  • 51 Tillmann H L, Heringlake S, Trauwein C. et al . Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection.  Hepatology . 1998;  28 379-384
    CrossrefPubMedGoogle Scholar
  • 52 Pessoa M G, Terrault N A, Ferrell L D. et al . Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation.  Hepatology . 1997;  25 1266-1270
    CrossrefPubMedGoogle Scholar
  • 53 Hassoba H M, Pessoa M G, Terrault N A. et al . Antienvelope antibodies are protective against GBV-C reinfection: evidence from the liver transplant model.  J Med Virol . 1998;  56 253-258
    CrossrefPubMedGoogle Scholar
  • 54 Brown K E, Tisdale J, Barrett A J, Dunbar C E, Young N S. Hepatitis-associated aplastic anemia.  N Engl J Med . 1997;  336 1059-1064
    CrossrefPubMedGoogle Scholar
  • 55 Moriyama K, Okamura T, Nakano S. Hepatitis GB virus C genome in the serum of aplastic anaemia patients receiving frequent blood transfusions.  Br J Haematol . 1997;  96 864-867
    CrossrefPubMedGoogle Scholar
  • 56 Kanda T, Yokosuka O, Imazeki F. et al . GB virus-C RNA in Japanese patients with hepatocellular carcinoma and cirrhosis.  J Hepatol . 1997;  27 464-469
    CrossrefPubMedGoogle Scholar
  • 57 Kubo S, Nishiguchi S, Kuroki T. et al . Poor association of GBV-C viremia with hepatocellular carcinoma.  J Hepatol . 1997;  27 91-95
    CrossrefPubMedGoogle Scholar
  • 58 Tagger A, Donato F, Ribero M L. et al . A case-control study on GB virus C/hepatitis G virus infection and hepatocellular carcinoma. Brescia HCC Study.  Hepatology . 1997;  26 1653-1657
    PubMedGoogle Scholar
  • 59 Zignego A L, Giannini C, Gentilini P. et al . Could HGV infection be implicated in lymphomagenesis?.  Br J Haematol . 1997;  98 778-779
    CrossrefPubMedGoogle Scholar
  • 60 Fargion S, Sampietro M, Fracanzani A L. et al . Hepatitis G virus in patients with porphyria cutanea tarda (PCT).  J Hepatol . 1997;  26(Suppl) 207
    PubMedGoogle Scholar
  • 61 Nagao Y, Sata M, Noguchi S. et al . GB virus infection in patients with oral cancer and oral lichen planus.  J Oral Pathol Med . 1997;  26 138-141
    PubMedGoogle Scholar
  • 62 Goodnough L T, Brecher M E, Kanter M H, Aubuchon J P. Medical progress: transfusion medicine (first of two parts)-blood transfusion.  N Engl J Med . 1999;  340 438-447
    CrossrefPubMedGoogle Scholar
  • 63 Smith D B, Simmonds P, Frost S. et al . Phylogenetic analysis of GBV-C/hepatitis G virus.  J Gen Virol . 2000;  81 769-780
    PubMedGoogle Scholar
  • 64 Simons J N, Desai S M, Schultz D E, Lemon S M, Mushahwar I K. Translation initiation in GB viruses A and C: evidence for internal ribosome entry and implications for genomic organization.  J Virol . 1996;  70 6126-6135
    PubMedGoogle Scholar
  • 65 Xiang J, Klinzman D, McLinden J. et al . Characterization of hepatitis G virus (GB-C virus) particles: evidence for a nucleocapsid and expression of sequences upstream of the E1 protein.  J Virol . 1998;  72 2738-2744
    PubMedGoogle Scholar
  • 66 Xiang J, Daniels K J, Soll D R. et al . Visualization and characterization of GB virus C (hepatitis G virus) particles: evidence for a nucleocapsid.  J Viral Hepat . 1999;  6 S16-S22
    CrossrefPubMedGoogle Scholar
  • 67 Wunschmann S, Klinzman D, Medh J. et al . Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low density lipoprotein receptor.  J Virol . 2000;  74 10055-10062
    CrossrefPubMedGoogle Scholar
  • 68 Agnello V, Abel G, Elfahal M, Knight G B, Zhang X. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor.  Proc Natl Acad Sci USA . 1999;  96 12766-12771
    CrossrefPubMedGoogle Scholar
  • 69 Monazahian M, Bohme I, Bonk S. et al . Low density lipoprotein receptor as a candidate receptor for hepatitis C virus.  J Med Virol . 1999;  57 223-229
    CrossrefPubMedGoogle Scholar
  • 70 Thomssen R, Bonk S, Propfe C. et al . Association of hepatitis C virus in human sera with beta-lipoproteins.  Med Microbiol Immunol . 1992;  181 293-300
    CrossrefPubMedGoogle Scholar
  • 71 Khudyakov Y E, Cong M-E, Bonafonte M-T. et al . Sequence variation within a nonstructural region of the hepatitis G virus genome.  J Virol . 1997;  71 6875-6880
    PubMedGoogle Scholar
  • 72 Belyaev A S, Chong S, Novikov A. et al . Hepatitis G virus encodes protease activities which can effect processing of the virus putative nonstructural proteins.  J Virol . 1998;  72 868-872
    PubMedGoogle Scholar
  • 73 Saito S, Tanaka K, Kondo M. et al . Plus- and minus-stranded hepatitis G virus RNA in liver tissue and in peripheral blood mononuclear cells.  Biochem Biophys Res Commun . 1997;  237 288-291
    CrossrefPubMedGoogle Scholar
  • 74 Sergi C, Jundt K, Seipp S. et al . The distribution of HBV, HCV, and HGV among livers with fulminant hepatic failure of different aetiology.  J Hepatol . 1998;  29 861-871
    CrossrefPubMedGoogle Scholar
  • 75 Ikeda M, Sugiyama K, Mizutani T. et al . Hepatitis G virus replication in human cultured cells displaying susceptibility to hepatitis C virus infection.  Biochem Biophys Res Commun . 1997;  235 505-508
    CrossrefPubMedGoogle Scholar
  • 76 Seipp S, Scheidel M, Hofmann W J. et al . Hepatotropism of GB virus C (GBV-C): GBV-C replication in human hepatocytes and cells of human hepatoma cell lines.  J Hepatol . 1999;  30 570-579
    CrossrefPubMedGoogle Scholar
  • 77 Mellor J, Haydon G, Blair C. et al . Low level or absent in vitro replication of hepatitis C virus and hepatitis G virus/ GB virus C in peripheral blood mononuclear cells.  J Gen Virol . 1998;  79 705-714
    PubMedGoogle Scholar
  • 78 Laskus T, Radkowski M, Wang L F, Vargas H, Rakela J. Detection of hepatitis G virus replication sites by using highly strand-specific Tth-based reverse transcriptase PCR.  J Virol . 1998;  72 3072-3075
    PubMedGoogle Scholar
  • 79 Radkowski M, Kubicka J, Kisiel E. et al . Detection of active hepatitis C virus and hepatitis G virus/GB virus C replication in bone marrow in human subjects.  Blood . 2000;  95 3986-3989
    PubMedGoogle Scholar
  • 80 Pessoa M G, Terrault N A, Detmer J. et al . Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic.  Hepatology . 1998;  27 877-880
    CrossrefPubMedGoogle Scholar
  • 81 Tucker T J, Smuts H EM, Eedes C. et al . Evidence that the GBV-C/hepatitits C virus is primarily a lymphotropic virus.  J Med Virol . 2000;  61 52-58
    CrossrefPubMedGoogle Scholar
  • 82 George S L, Klinzman D, Xiang J, Stapleton J T. Different GBV-C Replication phenotypes in in vitro culture models. Presented at the Retrovirus Conference. February 25, 2002; Seattle, WA
    Google Scholar
  • 83 Xiang J, Wunschmann S, Schmidt W N, Shao J, Stapleton J T. In vitro replication of a GB virus C infectious clone. In: Margolis H, Alter MJ, Liang TJ, Dienstag JL, eds. Viral Hepatitis and Liver Disease London: International Medical Press 2002: 464-468
    Google Scholar
  • 84 George S L, Gebhardt J, Klinzman D. et al . Hepatitis C virus (HCV) viremia in HIV-infected individuals with negative HCV antibody tests.  J Acquir Immune Defic Syndr . 2002;  31 154-162
    PubMedGoogle Scholar
  • 85 George S L, Klinzman D, Schmidt W N. et al .Antibody negative HCV infection in HIV positive individuals. In: Margolis H, Alter MJ, Liang TJ, Dienstag JL, eds. Viral Hepatitis and Liver Disease London: International Medical Press 2002 : 357-361
    Google Scholar
  • 86 Yeo A ET, Matsumoto A, Hisada M. et al . Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia.  Ann Intern Med . 2000;  132 959-963
    PubMedGoogle Scholar
  • 87 Rey D, Vidinic-Moularde J, Meyer P. et al . High prevalence of GB virus C/hepatitis G virus RNA and antibodies in patients infected with human immunodeficiency virus type 1.  Eur J Clin Microbiol Infect Dis . 2000;  19 721-724
    CrossrefPubMedGoogle Scholar
  • 88 Tillmann H L, Manns M P. GB virus-C infection in patients infected with the human immunodeficiency virus.  Antiviral Res . 2001;  52 83-90
    CrossrefPubMedGoogle Scholar
  • 89 George S L, Wunschmann S, McCoy J, Xiang J, Stapleton J T. Interactions between GB Virus Type C and HIV.  Curr Infect Dis Rep . 2002;  4 550-558
    PubMedGoogle Scholar
  • 90 Toyoda H, Fukuda Y, Hayakawa T, Takamatsu J, Saito H. Effect of GB virus C/hepatitis G virus co-infection on the course of HIV infection in hemophilia patients in Japan.  J Acquir Immune Defic Syndr . 1998;  17 209-213
    PubMedGoogle Scholar
  • 91 Sabin C A, Devereux H, Kinson Z. et al . Effect of co-infection with hepatitis G virus on HIV disease progression in hemophilic men.  J Acquir Immune Defic Syndr . 1998;  19 546-547
    PubMedGoogle Scholar
  • 92 Lefrère J J, Roudot-Thoraval F, Morand-Joubert L. et al . Carriage of GB Virus C/Hepatitis G Virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons.  J Infect Dis . 1999;  179 783-789
    CrossrefPubMedGoogle Scholar
  • 93 Macalalad A R, Snydman D R. GB virus C and mortality from HIV infection.  N Engl J Med . 2002;  346 377-379
    CrossrefPubMedGoogle Scholar
  • 94 Stapleton J T, Diekema D J, Xiang J. GB virus C and mortality from HIV infection.  N Engl J Med . 2002;  346 377-379
    CrossrefPubMedGoogle Scholar
  • 95 Rodriguez B, Valdez H, Lederman M M. Effect of hepatitis G co-infection on response to antiretroviral treatment in HIV-infected patients. Presented at the 39th Infectious Diseases Society of America Meeting. 2001; San Francisco, CA. Abstract 698
    Google Scholar
  • 96 Nunnari G, Nigro L, Palermo F. et al .Slower progression of HIV-1-infection in HGV/GB virus C co-infected individuals correlates with an intact T helper 1 cytokine profile. Presented at the Retrovirus Conference. 2002; Seattle, WA
    Google Scholar
  • 97 Brust D, Jagannatha S, Herpin B. et al .Hepatitis G virus (HGV) infection does not prolong survival of patients with early-stage HIV disease: importance of baseline HIV viral load as a predictor of mortality. Presented at the XIV International AIDS Conference. 2002; Barcelona, Spain. WeOrC1378
    Google Scholar
  • 98 Birk M, Lindback S, Lidman C. No influence of GB virus C replication on the prognosis in a cohort of HIV-1-infected patients.  AIDS . 2002;  16 2482-2485
    CrossrefPubMedGoogle Scholar
  • 99 Fogeda M, Navas S, Martin J. et al . In vitro infection of human peripheral blood mononuclear cells by GB virus C/ hepatitis G virus.  J Virol . 1999;  73 4052-4061
    PubMedGoogle Scholar
  • 100 George S L, Stapleton J T, Stapleton J T. GBV-C replication in PBMC cultures occurs in B and T lymphocytes, and does not require T cell activation. Presented at the conference on Retroviruses and Opportunistic Infections. February 12, 2003; Boston, MA
    Google Scholar
  • 101 Xiang J, George S L, Wuenschmann S, Klinzman D, Stapleton J T. GBV-C infection inhibits CCR5 and CXCR4 HIV strains, and alters chemokine and cytokine gene expression in PBMC cultures. Presented at the Conference on Retroviruses and Opportunistic Infections. February 12, 2003; Boston, MA
    Google Scholar
  • 102 Mosier D E, Chisari F V. GB virus C and mortality from HIV infection.  N Engl J Med . 2002;  346 377-379
    CrossrefPubMedGoogle Scholar
      >